These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18050713)

  • 1. [Experience in implementing the mass immunization program against tick-borne encephalitis in the Sverdlovsk Region].
    Romanenko VV; Esiunina MS; Kiliachina AS
    Vopr Virusol; 2007; 52(6):22-5. PubMed ID: 18050713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccines, immunoglobulins, and test systems for the prevention and diagnosis of tick-borne encephalitis].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP
    Vopr Virusol; 2007; 52(6):30-6. PubMed ID: 18050715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new prospective vaccine against tick-borne encephalitis].
    Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria].
    Heinz F; Holtzmann H; Essl A; Kundt M
    Vopr Virusol; 2008; 53(2):19-27. PubMed ID: 18450105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of tick-borne encephalitis at the present stage: strategy and tactics].
    L'vov DK; Zlobin VI
    Vopr Virusol; 2007; 52(5):26-30. PubMed ID: 18041221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of tick-borne encephalitis: current aspects].
    Lashkevich VA; Karganova GG
    Vopr Virusol; 2007; 52(5):31-2. PubMed ID: 18041222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia.
    Craig SC; Pittman PR; Lewis TE; Rossi CA; Henchal EA; Kuschner RA; Martinez C; Kohlhase KF; Cuthie JC; Welch GE; Sanchez JL
    Am J Trop Med Hyg; 1999 Dec; 61(6):874-8. PubMed ID: 10674662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe tick-borne encephalitis in Slovenia in the years 2001-2005: time for a mass vaccination campaign?
    Jereb M; Karner P; Muzlovic I; Jurca T
    Wien Klin Wochenschr; 2006 Dec; 118(23-24):765-8. PubMed ID: 17186173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organization of supervision of tick-borne encephalitis and ways of its prevention in the Russian Federation].
    Onishchenko GG; Fedorov IuM; Pakskina ND
    Vopr Virusol; 2007; 52(5):8-10. PubMed ID: 18041217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.